Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies9
- 7D-0.4%
- 3M-4.5%
- 1Y-6.6%
- YTD-5.7%
In the last week, Biotech has been flat. As for the longer term, the industry has declined 6.6% in the last year. Looking forward, earnings are forecast to grow by 55% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | ₹631.9b | ₹177.1b | ₹5.5b | 56.7x | 115x | 3.6x |
| Tue, 06 Jan 2026 | ₹564.0b | ₹177.0b | ₹5.5b | 95.8x | 102.2x | 3.2x |
| Thu, 04 Dec 2025 | ₹588.7b | ₹177.0b | ₹5.5b | 91.3x | 106.7x | 3.3x |
| Sat, 01 Nov 2025 | ₹544.4b | ₹169.8b | ₹4.7b | 61.4x | 116.6x | 3.2x |
| Mon, 29 Sep 2025 | ₹500.0b | ₹169.4b | ₹4.6b | 59.7x | 108x | 3x |
| Wed, 27 Aug 2025 | ₹526.4b | ₹169.4b | ₹4.6b | 63.1x | 113.7x | 3.1x |
| Fri, 25 Jul 2025 | ₹579.7b | ₹163.7b | ₹10.6b | 55.1x | 54.6x | 3.5x |
| Sun, 22 Jun 2025 | ₹516.5b | ₹163.8b | ₹10.6b | 50.2x | 48.6x | 3.2x |
| Tue, 20 May 2025 | ₹464.1b | ₹163.8b | ₹10.6b | 57x | 43.8x | 2.8x |
| Thu, 17 Apr 2025 | ₹446.4b | ₹158.8b | ₹8.5b | 49x | 52.3x | 2.8x |
| Sat, 15 Mar 2025 | ₹428.3b | ₹158.9b | ₹8.4b | 48.1x | 51.3x | 2.7x |
| Mon, 10 Feb 2025 | ₹511.9b | ₹158.7b | ₹8.3b | 57.6x | 61.8x | 3.2x |
| Wed, 08 Jan 2025 | ₹514.3b | ₹159.6b | ₹14.5b | 63.5x | 35.4x | 3.2x |
| Fri, 06 Dec 2024 | ₹507.8b | ₹159.6b | ₹14.5b | 43.6x | 34.9x | 3.2x |
| Sun, 03 Nov 2024 | ₹431.2b | ₹159.0b | ₹14.3b | 43.3x | 30.1x | 2.7x |
| Tue, 01 Oct 2024 | ₹483.6b | ₹157.7b | ₹15.7b | 33.9x | 30.8x | 3.1x |
| Thu, 29 Aug 2024 | ₹471.6b | ₹157.7b | ₹15.7b | 37.5x | 30x | 3x |
| Sat, 27 Jul 2024 | ₹485.8b | ₹157.4b | ₹10.4b | 51.1x | 46.9x | 3.1x |
| Mon, 24 Jun 2024 | ₹449.2b | ₹157.4b | ₹10.4b | 44.8x | 43.2x | 2.9x |
| Wed, 22 May 2024 | ₹397.4b | ₹157.0b | ₹10.2b | 45.6x | 38.9x | 2.5x |
| Fri, 19 Apr 2024 | ₹348.7b | ₹155.4b | ₹12.0b | 35.7x | 29x | 2.2x |
| Sun, 17 Mar 2024 | ₹327.2b | ₹155.4b | ₹12.0b | 33.3x | 27.2x | 2.1x |
| Tue, 13 Feb 2024 | ₹348.3b | ₹155.0b | ₹12.2b | 53.6x | 28.5x | 2.2x |
| Thu, 11 Jan 2024 | ₹369.4b | ₹145.0b | ₹5.3b | 60.2x | 70.3x | 2.5x |
| Sat, 09 Dec 2023 | ₹315.7b | ₹145.0b | ₹5.3b | 53x | 60.1x | 2.2x |
| Mon, 06 Nov 2023 | ₹298.6b | ₹133.3b | ₹4.7b | 42.9x | 63.3x | 2.2x |
| Wed, 04 Oct 2023 | ₹355.5b | ₹133.8b | ₹4.8b | 31x | 74.4x | 2.7x |
| Fri, 01 Sep 2023 | ₹440.4b | ₹142.3b | ₹7.2b | 35.5x | 61.3x | 3.1x |
| Sun, 30 Jul 2023 | ₹335.4b | ₹120.4b | ₹4.5b | 43.3x | 74.4x | 2.8x |
| Tue, 27 Jun 2023 | ₹314.2b | ₹120.4b | ₹4.5b | 41.4x | 69.7x | 2.6x |
| Thu, 25 May 2023 | ₹319.5b | ₹124.2b | ₹17.0b | 27.5x | 18.8x | 2.6x |
| Sat, 22 Apr 2023 | ₹304.4b | ₹106.6b | ₹16.4b | 15.5x | 18.6x | 2.9x |
| Mon, 20 Mar 2023 | ₹271.0b | ₹106.5b | ₹16.3b | 31.4x | 16.6x | 2.5x |
| Wed, 15 Feb 2023 | ₹312.2b | ₹99.0b | ₹17.9b | 29.9x | 17.5x | 3.2x |
Price to Earnings Ratio
17.5x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 115x which is higher than its 3-year average PE of 56.2x.
- The 3-year average PS ratio of 2.8x is lower than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 33% per year over the last three years.
- Meanwhile revenues for these companies have grown 21% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 1.60% | |
| Healthcare | 1.53% | |
| Biotech | -0.40% | |
| Biotech | -0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 524669 Hester Biosciences | ₹1.51k | 1.6% +₹198.2m | -19.6% | PE31.3x | |
| 524663 Bharat Immunologicals & Biologicals | ₹20.15 | 12.3% +₹95.0m | -19.2% | n/a | |
| NIRMAN Nirman Agri Genetics | ₹63.50 | 20.0% +₹84.9m | -81.6% | PE1.8x | |
| 532039 Zenotech Laboratories | ₹45.70 | 2.1% +₹57.4m | -27.3% | PE83x | |
| 532041 Hindustan Bio Sciences | ₹8.18 | 21.0% +₹14.6m | -14.3% | PE56.7x |